Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001789769-22-000051
Filing Date
2022-05-25
Accepted
2022-05-25 18:02:45
Documents
1
Period of Report
2022-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165351614718058.html 4  
1 FORM 4 wf-form4_165351614718058.xml 4 3912
  Complete submission text file 0001789769-22-000051.txt   5292
Mailing Address C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET, SUITE 1100 CAMBRIDGE MA 02142
Business Address
Nielsen Jack (Reporting) CIK: 0001602402 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40215 | Film No.: 22964376

Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Issuer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)